Recombinant PDCD1 (Camrelizumab Biosimilar) antibody

Catalog No. ABIN7488116

This Mammalian Cells Monoclonal antibody specifically detects PDCD1 (Camrelizumab Biosimilar) in ELISA. It exhibits reactivity toward Human.

Quick Overview for Recombinant PDCD1 (Camrelizumab Biosimilar) antibody (ABIN7488116)

Target: PDCD1 (Camrelizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Mammalian Cells

Clonality: Monoclonal

Conjugate: This PDCD1 (Camrelizumab Biosimilar) antibody is un-conjugated

Application: ELISA

Grade: Research Grade

Product Details anti-PDCD1 (Camrelizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Camrelizumab Biosimilar - Anti-PDCD1, PD-1, CD279 mAb

Characteristics: Antibody Type: IgG4-kappa

Purification: Recombinant antibody expressed in mammalien cells and purified.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Buffer: PBS pH 7.5

Storage: -80 °C

Storage Comment: store at -80°C

Target Details for PDCD1 (Camrelizumab Biosimilar)

Target: PDCD1 (Camrelizumab Biosimilar)

Target Type: Biosimilar

Background: SHR-1210
Camrelizumab is an IgG4κ humanized monoclonal antibody being investigated for hepatocellular carcinoma. It targets programmed cell death protein 1 (PD-1), a protein on the surface of cells, also known as CD279 (cluster of differentiation 279).

CAS-No: 1798286-48-2